{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:38:00Z","timestamp":1787071080337,"version":"build-2736575974"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:p>Gestational trophoblastic neoplasia (GTN) is a rare disease and is characterized by an abnormal proliferation of trophoblastic cells of placenta. Since majority of them are chemotherapy sensitive, they are one of the highly curable cancers. However, due to its varied presentation, clinicians still face many challenges in its diagnosis and management. We present a case of 26-year-old woman, P0 + 3 (previous 3 abortions) who presented to us with a history of vaginal bleeding postuterine evacuation after 2 months of incomplete abortion. After clinical, radiological assessment and high human chorionic gonadotropin (hCG) titers, the patient was diagnosed as a case of cervical GTN. Risk assessment by the WHO prognostic scoring system was done and \u201cLow Risk\u201d was assigned to her. She was given total nine cycles of single agent chemotherapy including two consolidation cycles after normalization of hCG titers which patient tolerated well and remained asymptomatic.<\/jats:p>","DOI":"10.4103\/jcrt.jcrt_959_20","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T04:10:27Z","timestamp":1658808627000},"page":"827-830","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Cervical gestational trophoblastic neoplasia: A rare form of gestational trophoblastic disease"],"prefix":"10.4103","volume":"18","author":[{"given":"Shyam Pyari","family":"Jaiswar","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, King George Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, King George Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata","family":"Deo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, King George Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumaiya","family":"Saad","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, King George Medical University, Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,7,25]]},"reference":[{"key":"R1-20250514","first-page":"01","article-title":"Gestational trophoblastic disease: Dilemma and updates","volume":"3","author":"Verma","year":"2017","journal-title":"Onco Exp"},{"key":"R2-20250514","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/j.seminoncol.2005.11.002","article-title":"Hepatotoxicity of chemotherapy","volume":"33","author":"Floyd","year":"2006","journal-title":"Semin Oncol"},{"key":"R3-20250514","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2016.10.024","article-title":"Placental site trophoblastic tumors and epithelioid trophoblastic tumors: Biology, natural history, and treatment modalities","volume":"144","author":"Horowitz","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R4-20250514","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/IGC.0b013e31821a278d","article-title":"Differentiating squamous cell carcinoma of the cervix and epithelioid trophoblastic tumor","volume":"21","author":"Jordan","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"R5-20250514","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2298\/VSP141004041N","article-title":"Cervical poorly differentiated adenocarcinoma with dominant choriocarcinoma pattern \u2013 A case report","volume":"72","author":"Nikolic","year":"2015","journal-title":"Vojnosanit Pregl"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_959_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:41:11Z","timestamp":1787067671000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_959_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_959_20","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"2020-07-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}